KLOW is an advanced multi-peptide formulation developed for high-level scientific research. Each vial delivers a balanced combination of TB-500 (10 mg), BPC-157 (10 mg), GHK-Cu (50 mg), and KPV (10 mg) — four highly regarded research peptides known for their diverse roles in studies involving cellular signaling, tissue dynamics, and inflammatory response pathways.